In a first-of-its kind initiative, the National Institute of Ayurveda (NIA) under the Union Ministry of Ayush, the Tata Memorial Hospital, Mumbai, the Directorate General of Ayush of Jammu and Kashmir, and AIMIL Pharmaceuticals have joined hands to conduct clinical trials of ayurvedic anti-cancer drug 'V2S2' to test its efficacy.
Developed by NIA, the formula of V2S2 is prepared from hydro-alcoholic extracts of several medicinal plants.
Its anti-carcinogenic properties have been already confirmed in laboratory tests. It has also been found to be effective in increasing immunity and inhibiting the growth of cancer cells. The latest agreement has been inked for its formal in-vivo testing.
Responding to the signing of the pact, Jaipur-based NIA Vice Chancellor Sanjeev Sharma said the trials of the medicine on animals will start soon.
Sharma said: "These tests will be conducted at the Tata Memorial Hospital in Mumbai in a period spanning 9-12 months. Depending on the results, trials on humans will be done by the NIA and J&K Ayush department. The task of manufacturing the drug for the trials has been entrusted to AIMIL Pharmaceuticals, which will then launch it in the market for public consumption."
Describing the agreement as a milestone in the direction of cancer drug research, Sanchit Sharma, Executive Director at AIMIL Pharmaceuticals, said that in the next two-three years, ayurveda will be able to provide effective cancer treatment options to the patients.
He said the initial results of the drug were very encouraging, showing that it increases the immunity of humans and slows down the growth of cancer cells.
‘Pahalgam incident deeply disturbing & tragic’: Former Pakistan PM Imran Khan
Former Pakistan Prime Minister Imran Khan on Tuesday termed the Pahalgam terror attack as disturbing & tragic and also condoled the victims and their families.
Congress finally deletes 'Gayab' post targeting PM Modi after outrage
Under fire from the BJP over its social media post targeting Prime Minister Narendra Modi, Congress finally, on Tuesday, took down the controversial post.
Guterres calls EAM Jaishankar, Pak PM Sharif; stresses pursuing justice in Pahalgam terror attack
Secretary-General Antonio Guterres stressed the importance of pursuing justice in the Pahalgam terrorist attack while speaking with External Affairs Minister (EAM) S Jaishankar and Pakistan’s Prime Minister Muhammad Shebaz Sharif, his Spokesperson Stephane Dujarric said on Tuesday.
Congress organises ‘Save Constitution’ rallies across NE states
The opposition Congress has been organising ‘Samvidhan Bachao’ (Save Constitution) campaign in the northeastern states. Claiming that the Constitution is in danger under the BJP-led Central government, the opposition Congress held a massive rally in Agartala on Tuesday.
RSS chief Bhagwat meets PM Modi after security huddle: Signs of a hard-hitting response in the works
In a significant political development, RSS chief Mohan Bhagwat met Prime Minister Narendra Modi at his official residence at 7, Lok Kalyan Marg on Tuesday evening.
What PM Modi's free hand to armed forces against terror means for cross-border action?
Prime Minister Narendra Modi’s unambiguous message during a high-level security meeting - ‘India is determined to deliver a crushing blow to terrorism’ - marks more than just a strong statement of resolve.
Justice BR Gavai appointed as next Chief Justice of India
Justice Gavai was elevated as a Judge of the Supreme Court on May 29, 2019. Appointed as Additional Judge of the Bombay High Court in November 2003, he became a permanent Judge in November 2005.
Three more Bangladeshi nationals held in Tripura
The Tripura Frontier of the Border Security Force (BSF) on Tuesday apprehended three Bangladeshi nationals, including a woman, for illegally entering India, officials said.